Evidence map›Paper›PMID 41601775›Full record

SynthesisFrontiers in medicine2025

Beyond the vision: central serous chorioretinopathy, anxiety and depression-a systematic review.

Alessandro Meduri, Emanuele Maria Merlo, Giorgio Sparacino, Maura Mancini, Giovanni William Oliverio, Orlando Silvestro, Laura De Luca, Gabriella Martino, Pasquale Aragona

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alessandro Meduri *Ophthalmology Clinic, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
Emanuele Maria Merlo *Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
Giorgio SparacinoCourse Degree in Medicine and Surgery, University of Messina, Messina, Italy.
Maura ManciniOphthalmology Clinic, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
Giovanni William OliverioOphthalmology Clinic, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
Orlando SilvestroDepartment of Health Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
Laura De LucaOphthalmology Clinic, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
Gabriella MartinoDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Pasquale AragonaOphthalmology Clinic, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Central Serous Chorioretinopathy (CSCR) is an exudative maculopathy characterized by serous retinal detachment, choroidal hyperpermeability, and retinal pigment epithelium dysfunction. Beyond its ocular features, CSCR has long been associated with stress-related mechanisms and emotional dysregulation. Psychological factors such as anxiety and depression may influence disease onset, recurrence, and recovery; however, no previous review has systematically synthesized quantitative evidence on these variables in CSCR. Methods: This systematic review followed the PRISMA 2020 guidelines and was registered in PROSPERO (CRD420251160719). PubMed, Scopus, and Web of Science were searched in October 2025 using the terms Results: Across the included studies, depressive symptoms were significantly higher in CSCR patients in most investigations, indicating a consistent affective vulnerability. Findings for state anxiety were more heterogeneous, with approximately half of the studies reporting significant group differences. Evidence on trait anxiety was limited but suggested potential links with physiological dysregulation, including altered neurovascular coupling. Overall, psychological distress-particularly depressive symptoms-emerged as a frequent and clinically meaningful correlate of CSCR. Conclusion: The present review provides the first comprehensive synthesis of quantitative evidence linking anxiety and depression with CSCR. These findings highlight the need for routine psychological screening and integrative management in ophthalmology. Future longitudinal and interventional research is warranted to clarify causal pathways and evaluate targeted psychological or stress-reduction interventions, ultimately promoting holistic care that addresses both the visual and emotional dimensions of this condition. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251160719.

Indexed as

anxietycentral serous chorioretinopathyclinical psychologydepressionmaculopathyophthalmologypsychopathology

Identifiers

PMID41601775
PMCPMC12832727

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.